ICRA Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 31 May 2026 | Capital Markets | Market Cap: ₹4.9K Cr

The acquisition of Fintellix provides a strong platform for growth in the Research and Analytics (R&A) segment over the next 2-3 years, helping offset moderation in knowledge services. Ratings business is expected to maintain steady growth with potential double-digit revenue growth leading to some margin improvement due to operating leverage.

From ICRA Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

4,965

Market Cap

₹4.9K Cr

P/E Ratio

25.2

Revenue Rank

Rank 3

Margin Rank

Rank 3

How does ICRA Ltd rank in Capital Markets?

Compare ICRA Ltd against every Capital Markets company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 3Margin: Rank 3
View Capital Markets leaderboard →

ICRA Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹175 Cr, net profit ₹53 Cr.

Full financials →

📊 Revenue & Sales Performance

Rank 3
  • The acquisition of Fintellix provides a strong platform for growth in the Research and Analytics (R&A) segment over the next 2-3 years, helping offset moderation in knowledge services.
  • The Ratings business expects double-digit revenue growth, driven primarily by growth in bank credit, despite subdued bond market activity.
  • Non-Knowledge Services (non-KS) parts of Analytics are expected to maintain modest growth; however, growth has been muted in some areas like knowledge services.
  • The company is focused on expanding globally, enhancing product offerings especially in regulatory, risk modeling, and data infrastructure, supported by increasing regulatory intensity and AI adoption.
  • Growth outlook remains reasonable but is not explicitly quantified, with ongoing investments in AI and technology aimed at sustaining long-term growth.
  • Capital Markets and Banking divisions will explore new adjacent areas, but the core product portfolio in non-rating businesses is largely complete.
  • Overall growth in FY27 is expected around 20%, excluding currency and other transient effects.

📈 Profitability & Margins

Rank 3
  • Ratings business is expected to maintain steady growth with potential double-digit revenue growth leading to some margin improvement due to operating leverage.
  • Research and Analytics (R&A) segment to see reasonable growth driven by Fintellix acquisition and expansion in risk, regulatory, and data analytics solutions.
  • Growth in the Knowledge Services (KnowTech) sub-segment is moderating, but this is offset by growth in BankTech and CapTech verticals.
  • EBITDA margins in product-led R&A businesses (BankTech, CapTech) expected in the range of 20%-35%, with margin profile evolving due to geographic and business mix shifts.
  • Overall company growth for FY26 was around 20%, and steady-state growth in operating profits is expected at a similar magnitude (~20%), excluding one-time effects.
  • No specific guidance on EPS, but dividend payouts have increased, with continued focus on balancing growth investments and shareholder returns.
  • Strategic focus on AI adoption and scaling product-led solutions is expected to drive sustainable profit growth.

🏗️ Capital Expenditure Plans

No information
  • The company continues ongoing investments in analytics platforms, compliance capabilities, and scalable delivery frameworks to support evolving market needs and drive long-term growth in the research and analytics business (Page 4).
  • Internal product evolution is planned, especially integrating AI advancements and next iterations of existing products to bridge gaps and enhance offerings (Page 11).
  • While the product portfolio in non-rating businesses is largely complete, exploration of adjacencies and new areas for growth continues, implying possible future strategic investments (Page 11).
  • No specific capex or large-scale strategic investment figures or plans were disclosed, but the company follows a disciplined capital allocation framework with Board review and approval for acquisitions and investments (Page 14).
  • Dividend payouts have increased steadily, and alternative capital allocation options, including potential buybacks, are being evaluated amid changing tax rules (Page 11).

💰 Fundraising & Capital Structure

No information
  • There is no explicit mention in the provided transcript of any current or future fundraising plans through debt or equity.
  • The discussion around capital allocation indicates a strong cash position with over INR 700 crores of net cash.
  • Management notes they are open to evaluating capital allocation options, including returning money to shareholders, but no concrete fundraising plans are shared.
  • Dividend payout has been consistently increased, with considerations ongoing regarding alternate uses of cash.
  • No specific mention of plans for new debt or equity issuance in the near future.

📋 Order Book & Pipeline

No information
The transcript does not explicitly mention current or expected orderbook/pending orders details. However, related points are: - Growth in risk management and market data verticals within Research & Analytics has been healthy, indicating ongoing project wins. - Post-acquisition integration of Fintellix and D2K is progressing, expanding footprint and solution offerings in large customers, which may boost order intake. - There are ongoing regulatory-driven opportunities and greenfield projects in capital markets and banking divisions. - Management emphasizes pursuing new adjacencies and evolving product offerings to capture fresh opportunities. - The outlook mentions expected reasonable growth driven by acquisitions but no specific order backlog numbers or timelines are disclosed. No direct data on pending orders or confirmed order book size is provided in the call transcript.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

No information

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were ICRA Ltd Q4 FY26 results?

The acquisition of Fintellix provides a strong platform for growth in the Research and Analytics (R&A) segment over the next 2-3 years, helping offset moderation in knowledge services. Ratings business is expected to maintain steady growth with potential double-digit revenue growth leading to some margin improvement due to operating leverage.

What is ICRA Ltd share price analysis?

ICRA Ltd currently shows a below-average growth signal. The stock trades at a P/E of 25.2 with a market cap of ₹4,943 Cr. Investors should review the full earnings analysis for detailed insights.

Is ICRA Ltd planning capital expenditure?

The company continues ongoing investments in analytics platforms, compliance capabilities, and scalable delivery frameworks to support evolving market needs and drive long-term growth in the research and analytics business (Page 4).

Keep ICRA Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What ICRA's management said in earlier quarters

Others in Capital Markets this season

  • Indian Energy Ex (Q4 FY26)

    FY26 electricity volume rose 17% YoY to 141 billion units, with RTM volumes growing 41% and green market volumes up 23% YoY, indicating strong growth momentum…

  • SMC Global Securities Ltd (Q4 FY26)

    SIP flow monthly sourcing is around INR 25.69 crores contributed by about 94,392 live SIPs. Key concall takeaways from SMC Global Securities Ltd's Q4 FY26…

  • IIFL Capital (Q4 FY26)

    The company is well capitalized with sufficient "dry powder" for growth, with net worth increasing from INR1,000 crores to over INR3,000 crores in 4 years…

  • Prudent Corp. (Q4 FY26)

    Health insurance fresh premium grew 35%, life insurance by 28%, with confidence in continued growth despite regulatory yield adjustments. Key concall takeaways…